Back

ASCO-GU 2019 - ASCO Genitourinary Cancers Symposium

Feb 14 - Feb 16, 2019 | San FranciscoCAUS

LARVOL is not affiliated with ASCO Genitourinary Cancers Symposium and all trademarks, logos, and brand names are property of their respective owners

Showing 364 abstracts linked to Trials

A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO).

  • Poster
1 Twitter Reactions